Edition:
United Kingdom

TESARO Inc (TSRO.OQ)

TSRO.OQ on NASDAQ Stock Exchange Global Select Market

74.94USD
2:40pm GMT
Change (% chg)

$0.00 (+0.01%)
Prev Close
$74.94
Open
$74.94
Day's High
$74.95
Day's Low
$74.94
Volume
24,610
Avg. Vol
773,181
52-wk High
$74.95
52-wk Low
$23.50

Chart for

About

TESARO, Inc. is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.... (more)

Overall

Beta: 1.67
Market Cap(Mil.): $6,492.51
Shares Outstanding(Mil.): 54.18
Dividend: --
Yield (%): --

Financials

  TSRO.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -9.94 -- --
ROI: -125.62 8.99 14.48
ROE: -185.12 10.13 15.99

GlaxoSmithKline to look for early-stage assets - CEO

Jan 8 GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the British drugmaker's chief executive officer said on Tuesday.

08 Jan 2019

REFILE-EMEA lending rises to US$1.05trn in 2018

LONDON, Jan 3 (LPC) - Syndicated lending in Europe, the Middle East and Africa in 2018 broke the trillion dollar mark for the first time in three years as volume rose 17.4% to US$1.05trn due to increased refinancing activity and stable levels of M&A financing, according to LPC data.

03 Jan 2019

Drugmaker GSK to split after striking Pfizer consumer health deal

LONDON GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's consumer health division. | Video

19 Dec 2018

Drugmaker GSK to split after striking Pfizer consumer health deal

LONDON GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's consumer health division. | Video

19 Dec 2018

UPDATE 2-Drugmaker GSK to split after striking Pfizer consumer health deal

* GSK shares up 7 percent (Adds CEO comments, latest shares, analyst reaction, advisers)

19 Dec 2018

US STOCKS-Relief rally boosts Wall Street on U.S.-China trade truce

(For a live blog on the U.S. stock market, click or type LIVE/ in an Eikon news window.) * U.S., China agree on a trade ceasefire for talks * Technology, industrials sectors support S&P * Energy shares jump as oil prices rebound * Tesaro shares soar on Glaxo buyout deal * Indexes up: Dow 1.13 pct, S&P 1.09 pct, Nasdaq 1.51 pct (Updates with close of U.S. trading) By Lewis Krauskopf Dec 3 Wall Street's major indexes rallied on Monday following a

03 Dec 2018

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion

LONDON GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new Chief Executive Emma Walmsley that unnerved investors. | Video

03 Dec 2018

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion

LONDON GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion (4 billion pounds), a costly investment to rebuild the pharmaceuticals business by new Chief Executive Emma Walmsley that unnerved investors. | Video

03 Dec 2018

Deals of the day-Mergers and acquisitions

Dec 3 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

03 Dec 2018

US STOCKS-U.S.-China trade truce boosts Wall Street

* Indexes up: Dow 0.91 pct, S&P 0.86 pct, Nasdaq 1.19 pct (Adds late afternoon trading)

03 Dec 2018

Earnings vs. Estimates